Reaction
Parathyroid Disorder reporting signals
As of the last recalculation, Parathyroid Disorder appears in 796 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is PARICALCITOL (PRR 45.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Paricalcitol | 24 | 45.8 | 45.9 |
| Tofacitinib Citrate | 17 | 34.6 | 34.7 |
| Calcitriol Capsules 0.25 Mcg | 20 | 26.7 | 26.8 |
| Calcitriol Capsules 0.5 Mcg | 20 | 26.7 | 26.8 |
| Calcitriol | 20 | 26.4 | 26.5 |
| Cinacalcet Hydrochloride | 42 | 24.8 | 24.8 |
| Teriparatide | 40 | 9.7 | 9.7 |
| Denosumab | 61 | 8.4 | 8.4 |
| Abaloparatide | 5 | 4.5 | 4.5 |